Azitra (AZTR) EBIT (2022 - 2026)
Azitra (AZTR) posted EBIT of -$3.9 million for Q1 2026, down 73.56% on a QoQ basis from -$2.3 million in Q4 2025, and down 26.89% year-over-year from -$5.4 million in Q1 2025.
Azitra (AZTR) EBIT (2022 - 2026) Analysis & Trends
Azitra's EBIT history runs 5 years deep, the most recent figure standing at -$3.9 million for Q1 2026.
- Quarterly EBIT fell 26.89% year-over-year to -$3.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$11.8 million (down 6.44% YoY) and the FY2025 annual result came in at -$11.0 million, changed 0.17% from the prior year.
- EBIT was -$3.9 million for Q1 2026 at Azitra, down from -$2.3 million in the prior quarter.
- Across five years, EBIT topped out at -$1.4 million in Q2 2023 and bottomed at -$3.9 million in Q1 2026.
- A 5-year average of -$2.5 million and a median of -$2.6 million in 2023 frame the typical range for EBIT.
- Annual changes were most pronounced in 2023 — EBIT soared 31.64% — and 2024, when it tumbled 89.99%.
- Azitra's EBIT stood at -$2.7 million in 2022, then climbed by 8.44% to -$2.5 million in 2023, then grew by 1.47% to -$2.4 million in 2024, then rose by 6.88% to -$2.3 million in 2025, then sank by 73.56% to -$3.9 million in 2026.
- Business Quant data shows AZTR's EBIT at -$3.9 million in Q1 2026, -$2.3 million in Q4 2025, and -$2.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,785.82 Bn | 1,785.76 Bn | - | - |
| 2 | Akari Therapeutics | 979.03 Bn | 979.03 Bn | - | -15.76 Mn |
| 3 | BeOne Medicines | 473.13 Bn | 468.34 Bn | 1.35 Bn | 249.90 Mn |
| 4 | Vertex Pharmaceuticals | 123.67 Bn | 116.43 Bn | 2.59 Bn | 1.14 Bn |
| 5 | Regeneron Pharmaceuticals | 71.57 Bn | 62.81 Bn | 3.31 Bn | 642.90 Mn |
| 6 | Belite Bio | 62.00 Bn | 62.00 Bn | - | -32.68 Mn |
| 7 | Argenx Se | 54.61 Bn | 49.42 Bn | 1.41 Bn | 493.00 Mn |
| 8 | Alnylam Pharmaceuticals | 37.99 Bn | 34.98 Bn | 959.66 Mn | 268.64 Mn |
| 9 | Revolution Medicines | 36.09 Bn | 36.09 Bn | - | -445.22 Mn |
| 10 | Azitra | 2.07 Mn | 2.07 Mn | - | -3.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.93 Mn |
| Dec 31, 2025 | -2.27 Mn |
| Sep 30, 2025 | -2.77 Mn |
| Jun 30, 2025 | -2.87 Mn |
| Mar 31, 2025 | -3.10 Mn |
| Dec 31, 2024 | -2.43 Mn |
| Sep 30, 2024 | -2.93 Mn |
| Jun 30, 2024 | -2.66 Mn |
| Mar 31, 2024 | -2.96 Mn |
| Dec 31, 2023 | -2.47 Mn |
| Sep 30, 2023 | -1.99 Mn |
| Jun 30, 2023 | -1.43 Mn |
| Mar 31, 2023 | -1.56 Mn |
| Dec 31, 2022 | -2.70 Mn |
| Sep 30, 2022 | -2.37 Mn |
| Jun 30, 2022 | -2.09 Mn |